ZIVO Bioscience Receives 1 Million Bridge Financing
| ZIVODelisted Stock | USD 1.81 0.01 0.55% |
About 62% of Zivo Bioscience's investor base is looking to short. The analysis of overall sentiment of trading Zivo Bioscience stock suggests that many investors are alarmed at this time. Zivo Bioscience's investing sentiment overview a quick insight into current market opportunities from investing in Zivo Bioscience. Many technical investors use Zivo Bioscience stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Zivo |
BLOOMFIELD HILLS, Mich., April 05, 2023--Zivo Bioscience, Inc. , a biotechagtech RD company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced a 1 million unsecured six-month loan from its Chairman, Chief Executive Officer, and President, John Payne. The loan carries 10 percent simple interest, may be prepaid without penalty, is extendable for an additional six months and inclu
Read at finance.yahoo.com
 |
Zivo Bioscience Fundamental Analysis
We analyze Zivo Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zivo Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zivo Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Zivo Bioscience is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Zivo Bioscience Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zivo Bioscience stock to make a market-neutral strategy. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics with similar companies.
Peers
Zivo Bioscience Related Equities
| CVKD | Cadrenal Therapeutics, | 11.59 | ||||
| RNXT | RenovoRx | 8.70 | ||||
| FBRX | Forte Biosciences | 3.64 | ||||
| FHTX | Foghorn Therapeutics | 1.43 | ||||
| SNTI | Senti Biosciences | 0.25 | ||||
| TPST | Tempest Therapeutics | 1.39 | ||||
| KTTA | Pasithea Therapeutics | 1.50 | ||||
| ERAS | Erasca | 1.61 | ||||
| IKNA | Ikena Oncology | 3.73 | ||||
| QNRX | Quoin Pharmaceuticals | 12.31 |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |